FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3115809730> ?p ?o ?g. }

• W3115809730 endingPage "104716" @default.
• W3115809730 startingPage "104716" @default.
• W3115809730 abstract "The IL-33/ST2 axis is known to be involved in liver pathologies and IL-33 is over-expressed in mouse hepatitis models. We aimed to investigate the proposed protective effect of IL-33 in murine fulminant hepatitis induced by a Toll like receptor 3 (TLR3) viral mimetic, Poly I:C or by Concanavalin-A (ConA). The Balb/C mice were administered intravenously with ConA (15 mg/kg) or Poly I:C (30 μg/mouse) to induce acute hepatitis along with vehicle control. The recombinant mouse IL-33 (rIL-33) was injected (0.2 μg/mouse) to mice 2 h prior to ConA or Poly I:C injection to check its hepato-protective effects. The gross lesions, level of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), histopathology (H&E staining) and levels of IFNγ and TNFα were measured by ELISA. The gross pathological liver injury induced by Poly I:C or ConA was reduced by rIL-33 administration in mice. The levels of AST and ALT were significantly (P ≤ 0.05) higher in mice challenged with Poly I:C or ConA in comparison to control mice. The rIL-33 pre-treated mice in both Poly I:C and ConA challenge groups showed significantly (P ≤ 0.05) lower levels of AST and ALT, and decreased liver injury (parenchymal and per-vascular necrotic areas) in histological liver sections. The soluble levels of TNFα and IFNγ were significantly (P ≤ 0.05) raised in Poly I:C or ConA challenged mice than control mice. The levels of TNFα and IFNγ were significantly reduced (P ≤ 0.05) in rIL-33 pre-treated mice. In conclusion, the exogenous IL-33 administration mitigated liver injury and inflammation (decreased levels of IFNγ and TNFα) in Poly I:C and ConA-induced acute hepatitis in mice." @default.
• W3115809730 created "2021-01-05" @default.
• W3115809730 creator A5004024358 @default.
• W3115809730 creator A5009180661 @default.
• W3115809730 creator A5027915597 @default.
• W3115809730 creator A5044411163 @default.
• W3115809730 creator A5051040238 @default.
• W3115809730 creator A5072500232 @default.
• W3115809730 creator A5074480021 @default.
• W3115809730 creator A5082152381 @default.
• W3115809730 date "2021-01-01" @default.
• W3115809730 modified "2023-09-23" @default.
• W3115809730 title "IL-33 ameliorates liver injury and inflammation in Poly I:C and Concanavalin-A induced acute hepatitis" @default.
• W3115809730 cites W1490258901 @default.
• W3115809730 cites W1829679176 @default.
• W3115809730 cites W1970657386 @default.
• W3115809730 cites W1972541045 @default.
• W3115809730 cites W1977796210 @default.
• W3115809730 cites W2006845625 @default.
• W3115809730 cites W2010180179 @default.
• W3115809730 cites W2018645807 @default.
• W3115809730 cites W2044755612 @default.
• W3115809730 cites W2053791243 @default.
• W3115809730 cites W2070308698 @default.
• W3115809730 cites W2086665516 @default.
• W3115809730 cites W2086746877 @default.
• W3115809730 cites W2093396768 @default.
• W3115809730 cites W2097139406 @default.
• W3115809730 cites W2116258912 @default.
• W3115809730 cites W2144218024 @default.
• W3115809730 cites W2148079779 @default.
• W3115809730 cites W2157710399 @default.
• W3115809730 cites W2163824052 @default.
• W3115809730 cites W2298706705 @default.
• W3115809730 cites W2462776776 @default.
• W3115809730 cites W2521483984 @default.
• W3115809730 cites W2531233604 @default.
• W3115809730 cites W2557148924 @default.
• W3115809730 cites W2602692874 @default.
• W3115809730 cites W2608447092 @default.
• W3115809730 cites W2610536898 @default.
• W3115809730 cites W2612582419 @default.
• W3115809730 cites W2774330838 @default.
• W3115809730 cites W2779261498 @default.
• W3115809730 cites W2790753782 @default.
• W3115809730 cites W2791305067 @default.
• W3115809730 cites W2799958170 @default.
• W3115809730 cites W2883143502 @default.
• W3115809730 cites W2891612290 @default.
• W3115809730 cites W2898545691 @default.
• W3115809730 cites W2911037145 @default.
• W3115809730 cites W2974044228 @default.
• W3115809730 cites W3000220599 @default.
• W3115809730 doi "https://doi.org/10.1016/j.micpath.2020.104716" @default.
• W3115809730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33383149" @default.
• W3115809730 hasPublicationYear "2021" @default.
• W3115809730 type Work @default.
• W3115809730 sameAs 3115809730 @default.
• W3115809730 citedByCount "4" @default.
• W3115809730 countsByYear W31158097302021 @default.
• W3115809730 countsByYear W31158097302022 @default.
• W3115809730 countsByYear W31158097302023 @default.
• W3115809730 crossrefType "journal-article" @default.
• W3115809730 hasAuthorship W3115809730A5004024358 @default.
• W3115809730 hasAuthorship W3115809730A5009180661 @default.
• W3115809730 hasAuthorship W3115809730A5027915597 @default.
• W3115809730 hasAuthorship W3115809730A5044411163 @default.
• W3115809730 hasAuthorship W3115809730A5051040238 @default.
• W3115809730 hasAuthorship W3115809730A5072500232 @default.
• W3115809730 hasAuthorship W3115809730A5074480021 @default.
• W3115809730 hasAuthorship W3115809730A5082152381 @default.
• W3115809730 hasConcept C126322002 @default.
• W3115809730 hasConcept C134018914 @default.
• W3115809730 hasConcept C142724271 @default.
• W3115809730 hasConcept C185592680 @default.
• W3115809730 hasConcept C19869320 @default.
• W3115809730 hasConcept C202751555 @default.
• W3115809730 hasConcept C203014093 @default.
• W3115809730 hasConcept C2776029263 @default.
• W3115809730 hasConcept C2776637226 @default.
• W3115809730 hasConcept C2776914184 @default.
• W3115809730 hasConcept C2778606649 @default.
• W3115809730 hasConcept C2994395758 @default.
• W3115809730 hasConcept C544855455 @default.
• W3115809730 hasConcept C55493867 @default.
• W3115809730 hasConcept C71924100 @default.
• W3115809730 hasConceptScore W3115809730C126322002 @default.
• W3115809730 hasConceptScore W3115809730C134018914 @default.
• W3115809730 hasConceptScore W3115809730C142724271 @default.
• W3115809730 hasConceptScore W3115809730C185592680 @default.
• W3115809730 hasConceptScore W3115809730C19869320 @default.
• W3115809730 hasConceptScore W3115809730C202751555 @default.
• W3115809730 hasConceptScore W3115809730C203014093 @default.
• W3115809730 hasConceptScore W3115809730C2776029263 @default.
• W3115809730 hasConceptScore W3115809730C2776637226 @default.
• W3115809730 hasConceptScore W3115809730C2776914184 @default.
• W3115809730 hasConceptScore W3115809730C2778606649 @default.
• W3115809730 hasConceptScore W3115809730C2994395758 @default.

• next